DOI:
10.1055/s-00000025
Hormone and Metabolic Research
LinksClose Window
References
Lowe JR, Perry DJ, Salama AK. et al.
Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy.
J Immunother Cancer 2016;
4: 89
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.